Editorial : Next generation γδ T cell-based tumor immunotherapy

The discovery of the gd T-cell receptor (TCR) and its ability to confer potent
cytotoxic activity in CD3+ cells some 35 years ago sparked the initial proliferation in
research that garnered widespread interest in the biology and function of gd T cells.


Use and reproduction:

CC BY 4.0

Please note that individual components of the publication may be subject to other licensing or copyright conditions.


Citation style:
Could not load citation form.